| Literature DB >> 36161039 |
Sa'ed H Zyoud1,2,3.
Abstract
BACKGROUND: Clostridioides (Clostridium) difficile (C. difficile) is still the most common cause of healthcare-associated diarrhoea and is increasing in prevalence as a community-acquired infection. In addition, the emergence of antibiotic resistance in C. difficile can increase the likelihood of the disease developing and/or spreading. AIM: To provide an up-to-date picture of the trends in publications related to C. difficile infection, together with specific insights into hot-button issues in this field.Entities:
Keywords: Clostridium difficile; Bibliometric; Clostridioides; Diarrhoea; Scopus; VOSviewer
Mesh:
Year: 2022 PMID: 36161039 PMCID: PMC9372798 DOI: 10.3748/wjg.v28.i28.3720
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.374
Figure 1Annual number of publications on Clostridium difficile-associated diarrhea indexed in Scopus and published from 2001 to 2020.
Top 10 countries published Clostridium difficile-associated diarrhea between 2001 and 2020
|
|
|
|
|
| 1st | United States | 3585 | 44.11 |
| 2nd | United Kingdom | 1013 | 12.46 |
| 3rd | Canada | 556 | 6.84 |
| 4th | Germany | 434 | 5.34 |
| 5th | France | 383 | 4.71 |
| 6th | China | 315 | 3.88 |
| 7th | Netherlands | 273 | 3.36 |
| 8th | Australia | 261 | 3.21 |
| 9th | Italy | 244 | 3.00 |
| 10th | Spain | 238 | 2.93 |
Figure 2Network visualization map of country co-authorships. Of the 103 countries, 31 had at least 50 publications.
Ten most productive and influential institutions in Clostridium difficile-associated diarrhea between 2001 and 2020
|
|
|
|
|
|
| 1st |
| United Kingdom | 203 | 2.50 |
| 2nd |
| Netherlands | 191 | 2.35 |
| 3rd |
| United States | 183 | 2.25 |
| 4th |
| United States | 173 | 2.13 |
| 5th |
| United Kingdom | 160 | 1.97 |
| 6th |
| Israel | 135 | 1.66 |
| 7th |
| United States | 118 | 1.45 |
| 8th |
| United States | 115 | 1.42 |
| 9th |
| Australia | 109 | 1.34 |
| 10th |
| United States | 108 | 1.33 |
Top 10 related funding agencies in Clostridium difficile-associated diarrhea between 2001 and 2020
|
|
|
|
|
|
| 1st |
| United States | 884 | 10.88 |
| 2nd |
| United States | 841 | 10.35 |
| 3rd |
| United States | 539 | 6.63 |
| 4th |
| United States | 239 | 2.94 |
| 5th |
| United States | 171 | 2.10 |
| 6th |
| United States | 154 | 1.89 |
| 7th |
| United Kingdom | 150 | 1.85 |
| 8th |
| United States | 146 | 1.80 |
| 9th |
| United States | 137 | 1.69 |
| 10th |
| United Kingdom | 132 | 1.62 |
Ten most productive and influential journals in Clostridium difficile-associated diarrhea between 2001 and 2020
|
|
|
|
|
|
| 1st |
| 304 | 3.74 | 3.254 |
| 2nd |
| 276 | 3.4 | 3.331 |
| 3rd |
| 251 | 3.09 | 9.097 |
| 4th |
| 212 | 2.61 | 3.926 |
| 5th |
| 183 | 2.25 | 5.948 |
| 6th |
| 181 | 2.23 | 3.240 |
| 7th |
| 169 | 2.08 | 2.918 |
| 8th |
| 130 | 1.6 | 5.191 |
| 9th |
| 124 | 1.53 | 5.790 |
| 10th |
| 117 | 1.44 | 8.067 |
Impact factor (IF) based on Journal Citation Reports (JCR) 2020 from Clarivate Analytics.
Ten most cited publications and authors between 2001 and 2020 in in Clostridium difficile-associated diarrhea
|
|
|
|
|
|
|
|
| Cohen | “Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)” | 2010 |
| 2370 | 237.0 | 313.9 |
| van Nood | “Duodenal infusion of donor feces for recurrent clostridium difficile” | 2013 |
| 2140 | 305.7 | 241.3 |
| Loo | “A predominantly clonal multi-institutional outbreak of Clostridium difficile - Associated diarrhea with high morbidity and mortality” | 2005 |
| 1601 | 106.7 | 88.6 |
| Lessa | “Burden of Clostridium difficile infection in the United States” | 2015 |
| 1430 | 286.0 | 234.3 |
| Surawicz | “Guidelines for diagnosis, treatment, and prevention of clostridium difficile infections” | 2013 |
| 1087 | 155.3 | 116.8 |
| Louie | “Fidaxomicin versus vancomycin for Clostridium difficile infection” | 2011 |
| 1074 | 119.3 | 91.4 |
| Kelly and LaMont[ | “Clostridium difficile - More difficult than ever” | 2008 |
| 1019 | 84.9 | 68.1 |
| Rupnik | “Clostridium difficile infection: New developments in epidemiology and pathogenesis” | 2009 |
| 985 | 89.5 | 73.4 |
| Zar | “A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity” | 2007 |
| 935 | 71.9 | 58.9 |
| Pépin | “Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: A changing pattern of disease severity” | 2004 |
| 916 | 57.3 | 45.6 |
The impact index per article is presented based on Reference Citation Analysis [Source: Baishideng Publishing Group Inc. (Pleasanton, CA 94566, United States)].
Figure 3Network visualization map of the most frequent terms in the titles/abstracts of the retrieved documents. Of the 84961 terms, 385 had at least 100 publications. Terms with the same color represent a separate cluster (research theme).
Figure 4Overlay network visualization map of the most frequent terms in the titles/abstracts of the retrieved documents. The colors on the map reflected the period of emergence in the literature, with yellow representing terms that were relatively recent in the literature.